CAS 190786-44-8|Bepotastine Besilate
| Common Name | Bepotastine Besilate | ||
|---|---|---|---|
| CAS Number | 190786-44-8 | Molecular Weight | 547.063 |
| Density | / | Boiling Point | 546.8ºC at 760 mmHg |
| Molecular Formula | C27H31ClN2O6S | Melting Point | 161-163° |
| MSDS | / | Flash Point | 284.5ºC |
Names
| Name | bepotastine besylate |
|---|---|
| Synonym | More Synonyms |
Bepotastine Besilate BiologicalActivity
| Description | Bepotastine Beslilate (Bepreve) is a histamine H1 receptor anatagonist. IC50 value:Target: Histamine H1 receptorBepotastine Beslilate (Bepreve) also suppresses some allergic inflammatory processes such as allergic rhinitis, chronic urticaria or pruritus associated with skin conditions (eczema/dermatitis, prurigo or pruritus cutaneus).Bepotastine Beslilate (Bepreve) is useful for allergic conjunctivitis. |
|---|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>Histamine ReceptorSignaling Pathways >>Immunology/Inflammation >>Histamine ReceptorResearch Areas >>Inflammation/Immunology |
| References | [1]. Cho KH, Choi HG.Development of novel bepotastine salicylate salt bioequivalent to the commercial bepotastine besilate in beagle dogs.Drug Dev Ind Pharm. 2012 Sep 10. [2]. Meier EJ, Torkildsen GL, Gow JA, McNamara TR, Gomes PJ, Williams JI; for the Bepotastine Besilate Ophthalmic Solutions Study Group.Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic con [3]. Kawakami T, Kimura S, Haga T, Doi R, Kyoya M, Nakagawa K, Soma Y.Health-related quality of life assessed by the effect of bepotastine besilate in patients with pruritus: importance of emotions score in atopic dermatitis.J Dermatol. 2012 Jun;39(6):527-30. [4]. Williams JI, Kennedy KS, Gow JA, Torkildsen GL, Abelson MB, Gomes PJ, McNamara TR; Bepotastine Besilate Ophthalmic Solutions Study Group.Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic c [5]. Kida, Tetsuo; Fujii, Atsuko; Sakai, Osamu; Iemura, Masahito; Atsumi, Ikuyo; Wada, Tomoyuki; Sakaki, Hideyuki. Bepotastine besilate, a highly selective histamine H1 receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in i |
Chemical & Physical Properties
| Boiling Point | 546.8ºC at 760 mmHg |
|---|---|
| Melting Point | 161-163° |
| Molecular Formula | C27H31ClN2O6S |
| Molecular Weight | 547.063 |
| Flash Point | 284.5ºC |
| Exact Mass | 546.159119 |
| PSA | 125.41000 |
| LogP | 6.12220 |
| Vapour Pressure | 8.63E-13mmHg at 25°C |
| InChIKey | UDGHXQPQKQPSBB-BOXHHOBZSA-N |
| SMILES | O=C(O)CCCN1CCC(OC(c2ccc(Cl)cc2)c2ccccn2)CC1.O=S(=O)(O)c1ccccc1 |
Safety Information
| Hazard Codes | Xi |
|---|
Synonyms
| Bepotastine benzenesulfonate salt |
| UNII:6W18MO1QR3 |
| Bepotastine Besilate |
| benzenesulfonic acid,4-[4-[(S)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid |
| 4-{4-[(S)-(4-chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic acid benzenesulfonate |
| 4-{4-[(S)-(4-Chlorophenyl)(2-pyridinyl)methoxy]-1-piperidinyl}butanoic acid benzenesulfonate (1:1) |
| Talion |
| Bepotastine besylate |
| UNII-6W18MO1QR3 |
| TAU-284 |
| Bepotastine benzenesulfonate |
| Betotastine besilate |
| 1-Piperidinebutanoic acid, 4-[(S)-(4-chlorophenyl)-2-pyridinylmethoxy]-, benzenesulfonate (1:1) |
| Bepotastine (Beslilate) |
| Bepreve |
| 4-{4-[(S)-(4-Chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic acid benzenesulfonate (1:1) |
